Biosimilar Newsletter Archive

1. 05.28.20 -- Samsung Bioepis CEO: A COVID-19 Call To Action 5/28/2020
   05/28/20 Biosimilar Development Newsletter
2. 05.22.20 -- Top Considerations And Troubleshooting Tips For Protein Analysis 5/22/2020
   05/22/20 Biosimilar Development Newsletter
3. 05.21.20 -- A Wholesaler's View On Biologic Supply During Covid-19 5/21/2020
   05/21/20 Biosimilar Development Newsletter
4. 05.14.20 -- How Will Covid-19 Impact Biosimilars In The EU5? 5/14/2020
   05/14/20 Biosimilar Development Newsletter
5. 05.13.20 -- Integrating Automation And Data Science To Optimize Process Strategies 5/13/2020
   05/13/20 Biosimilar Development Newsletter
6. 05.07.20 -- What To Expect From FDA During, Post-Covid-19 5/7/2020
   05/07/20 Biosimilar Development Newsletter
7. 04.30.20 -- Biosimilars In An Election Year: What To Expect 4/30/2020
   04/30/20 Biosimilar Development Newsletter
8. 04.24.20 -- Strategies To Address Viral Vector Manufacturing 4/24/2020
   04/24/20 Biosimilar Development Newsletter
9. 04.23.20 -- Which Biosimilar Companies Will Thrive In 2025? 4/23/2020
   04/23/20 Biosimilar Development Newsletter
10. 04.19.20 -- Biosimilar Pipeline Sees 12 Percent Annual Growth 4/19/2020
    04/19/20 Biosimilar Development Newsletter